Want to see IVPR full AI Analyst Report?
Top Page
Inspire Veterinary Partners
(OTC:IVPR)
Select Model
Select Model
Rating:38Underperform
Price Target:
$0.03
▲(220.00% Upside)
Action:Reiterated
Date:01/22/26
The score is driven primarily by weak financial performance (negative profitability, high leverage, and negative operating/free cash flow) and bearish technical signals (below major moving averages with negative MACD). Additional downside risk comes from Nasdaq delisting and OTCQB move, while valuation is difficult to support due to a negative P/E and no dividend yield data.
Positive Factors
Strategic Growth Initiatives
The consulting agreement with 622 Capital LLC aims to enhance financial positioning and strategic growth, supporting long-term business development.
Negative Factors
High Leverage
High leverage can increase financial risk and limit flexibility, potentially impacting long-term financial stability and growth opportunities.
Read all positive and negative factors
Positive Factors
Negative Factors
Strategic Growth Initiatives
The consulting agreement with 622 Capital LLC aims to enhance financial positioning and strategic growth, supporting long-term business development.
Read all positive factors
Inspire Veterinary Partners (IVPR) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$18.30K
Dividend YieldN/A
Average Volume (3M)44.35M
Price to Earnings (P/E)―
Beta (1Y)8.23
Revenue Growth-8.76%
EPS Growth99.64%
CountryUS
Employees113
SectorConsumer Cyclical
Sector Strength84
IndustryAgricultural - Commodities/Milling
Share Statistics
EPS (TTM)-4.40
Shares Outstanding118,953,260
10 Day Avg. Volume132,839,515
30 Day Avg. Volume44,350,689
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)17.02
Price to Sales (P/S)1.60
P/FCF Ratio-2.60
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Inspire Veterinary Partners Business Overview & Revenue Model
Company Description
Inspire Veterinary Partners, Inc. manages and owns a network of veterinary hospitals located across the United States. The company's primary focus is general practice for small animals, catering to beloved companion pets like dogs and cats, with t...
How the Company Makes Money
Inspire Veterinary Partners generates revenue primarily by charging clients (pet owners) for veterinary medical services provided at its hospitals. Key revenue streams generally include (1) professional service fees for office visits, examinations...
Inspire Veterinary Partners Financial Statement Overview
Summary
Income Statement
35
Negative
Balance Sheet
25
Negative
Cash Flow
40
Negative
| Breakdown | TTM | Mar 2025 | Mar 2024 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 15.56M | 16.59M | 16.68M | 9.83M | 2.55M | 0.00 |
| Gross Profit | 4.73M | 3.29M | 3.55M | 2.55M | 829.29K | 0.00 |
| EBITDA | -8.36M | -9.50M | -10.84M | -2.91M | -977.46K | 0.00 |
| Net Income | -11.94M | -14.26M | -14.79M | -4.91M | -1.33M | -5.52K |
Balance Sheet | ||||||
| Total Assets | 23.96M | 20.20M | 21.79M | 20.19M | 6.33M | 21.97K |
| Cash, Cash Equivalents and Short-Term Investments | 341.75K | 523.69K | 178.96K | 444.25K | 2.06M | 21.97K |
| Total Debt | 13.94M | 16.37M | 18.42M | 23.61M | 6.69M | 0.00 |
| Total Liabilities | 19.79M | 18.63M | 22.58M | 25.32M | 7.20M | 0.00 |
| Stockholders Equity | 4.17M | 1.56M | -788.26K | -5.14M | -869.09K | 21.97K |
Cash Flow | ||||||
| Free Cash Flow | -4.34M | -10.24M | -4.20M | -2.84M | -2.32M | -5.52K |
| Operating Cash Flow | -4.23M | -10.01M | -3.82M | -2.66M | -1.01M | -5.52K |
| Investing Cash Flow | -1.96M | -237.98K | -1.87M | -14.67M | -4.02M | 0.00 |
| Financing Cash Flow | 5.89M | 10.59M | 5.63M | 15.71M | 7.07M | 269.16K |
Inspire Veterinary Partners Technical Analysis
Negative
0.01
Price Trends
0.16
Negative
0.54
Negative
0.92
Negative
Market Momentum
-0.04
Negative
32.78
Neutral
11.74
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IVPR, the sentiment is Negative. The current price of 0.01 is below the 20-day moving average (MA) of 0.04, below the 50-day MA of 0.16, and below the 200-day MA of 0.92, indicating a bearish trend. The MACD of -0.04 indicates Negative momentum. The RSI at 32.78 is Neutral, neither overbought nor oversold. The STOCH value of 11.74 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IVPR.
Inspire Veterinary Partners Risk Analysis
Inspire Veterinary Partners disclosed 48 risk factors in its most recent earnings report. Inspire Veterinary Partners reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Inspire Veterinary Partners Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | $4.42B | 22.10 | 47.30% | 0.79% | 14.02% | 31.92% | |
63 Neutral | $4.70B | 94.55 | 3.39% | ― | 20.38% | ― | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
56 Neutral | $103.57M | -25.15 | -18.26% | ― | ― | ― | |
54 Neutral | $1.82B | -19.84 | -5.21% | ― | 3.99% | 51.58% | |
40 Underperform | $2.81B | -2.29 | -50.02% | ― | 4.27% | -917.61% | |
38 Underperform | $18.30K | ― | -331.80% | ― | -8.76% | 99.64% |
* Consumer Cyclical Sector Average
IVPR
Inspire Veterinary Partners
0.01
-0.91
-98.91%
ACHC
Acadia Healthcare
28.55
5.59
24.35%
SGRY
Surgery Partners
13.69
-9.00
-39.67%
LFST
Lifestance Health Group
12.31
6.83
124.64%
CON
Concentra Group Holdings Parent, Inc.
34.26
10.70
45.40%
PARK
Park Dental Partners, Inc.
20.85
10.60
103.41%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.